We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Low Serum Chloride Aggravates Mortality Risk

By HospiMedica International staff writers
Posted on 21 Feb 2012
Hypochloremia appears to be a robust predictor of all-cause mortality among critically ill patients in the intensive care unit (ICU), according to a new study.

Researchers at Brigham and Women's Hospital (Boston, MA, USA) analyzed data regarding 51,789 critically ill patients at Massachusetts General and Brigham and Women's Hospital (Boston, MA, USA) from 1998 to 2009 to examine the hypothesis that abnormal chloride after admission to an ICU would be associated with increased mortality. More...
Patients were grouped into deciles of serum chloride values ranging from under 98 mEq/L (hypochloremia) to higher than 112 mEq/L (hyperchloremia). The primary endpoint was 30-day mortality, and all comparisons were versus the reference value of 107-108 mEq/L.

The results showed that patients with hypochloremic serum values had more than twofold higher 30-day mortality, compared with the reference value. The researchers also developed two models--one with and the other without sodium--that adjusted for age, gender, race, medical versus surgical patient, sepsis, creatinine, hematocrit, and other factors. They found that in the model that omitted sodium, serum chloride values remained predictors of increased mortality. After inclusion of sodium, hyperchloremia no longer predicted 30-day mortality risk, but remained an independent predictor of increased mortality up to 104 mEq/L. The study was presented as a poster session at the Society of Critical Care Medicine meeting, held during February 2012 in Houston (TX, USA).

“The present study illustrates a graded, independent relationship between chloride at critical-care initiation and 30-day all-cause mortality,” said study presenter Kenneth Christopher, MD. “Interestingly, hypochloremia is caused by excessive water, and that would include patients with syndrome of inappropriate antiduretic hormone, chronic heart failure, excess chloride loss, and patients on diuretics.”

Abnormal serum chloride values, either elevated or reduced, are common among ICU patients, but the mechanisms controlling this association have remained poorly understood. Studies of this known relationship have produced conflicting results, as some studies have shown an association, whereas others have identified hyperchloremia as a true mortality risk in critically ill patients; in general, however, hypochloremia is not a currently accepted as a risk factor.

Related Links:

Brigham and Women's Hospital




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.